Retinal Disease Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: RC3891B91A68EN
Market Monitor Global

Abstracts

Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on the inside back wall of your eye.

This report contains market size and forecasts of Retinal Disease Therapeutics in Global, including the following market information:

Global Retinal Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Retinal Disease Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Macular Degeneration Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Retinal Disease Therapeutics include Merck, Novartis, Allergan, Roche, Regeneron and Santen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Retinal Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Retinal Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Retinal Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Macular Degeneration
• Diabetic Macular Edema
• Diabetic Retinopathy
• Retinal Vein Occlusion

Global Retinal Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Retinal Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Others

Global Retinal Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Retinal Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Retinal Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Retinal Disease Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Novartis
• Allergan
• Roche
• Regeneron
• Santen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Retinal Disease Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Retinal Disease Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RETINAL DISEASE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Retinal Disease Therapeutics Market Size: 2021 VS 2028
2.2 Global Retinal Disease Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Retinal Disease Therapeutics Players in Global Market
3.2 Top Global Retinal Disease Therapeutics Companies Ranked by Revenue
3.3 Global Retinal Disease Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Retinal Disease Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Retinal Disease Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Retinal Disease Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Retinal Disease Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Retinal Disease Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Retinal Disease Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Macular Degeneration
  4.1.3 Diabetic Macular Edema
  4.1.4 Diabetic Retinopathy
  4.1.5 Retinal Vein Occlusion
4.2 By Type - Global Retinal Disease Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Retinal Disease Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Retinal Disease Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Retinal Disease Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Retinal Disease Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Others
5.2 By Application - Global Retinal Disease Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Retinal Disease Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Retinal Disease Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Retinal Disease Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Retinal Disease Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Retinal Disease Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Retinal Disease Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Retinal Disease Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Retinal Disease Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Retinal Disease Therapeutics Revenue, 2017-2028
  6.3.2 US Retinal Disease Therapeutics Market Size, 2017-2028
  6.3.3 Canada Retinal Disease Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Retinal Disease Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Retinal Disease Therapeutics Revenue, 2017-2028
  6.4.2 Germany Retinal Disease Therapeutics Market Size, 2017-2028
  6.4.3 France Retinal Disease Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Retinal Disease Therapeutics Market Size, 2017-2028
  6.4.5 Italy Retinal Disease Therapeutics Market Size, 2017-2028
  6.4.6 Russia Retinal Disease Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Retinal Disease Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Retinal Disease Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Retinal Disease Therapeutics Revenue, 2017-2028
  6.5.2 China Retinal Disease Therapeutics Market Size, 2017-2028
  6.5.3 Japan Retinal Disease Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Retinal Disease Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Retinal Disease Therapeutics Market Size, 2017-2028
  6.5.6 India Retinal Disease Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Retinal Disease Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Retinal Disease Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Retinal Disease Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Retinal Disease Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Retinal Disease Therapeutics Market Size, 2017-2028
  6.7.3 Israel Retinal Disease Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Retinal Disease Therapeutics Market Size, 2017-2028
  6.7.5 UAE Retinal Disease Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Retinal Disease Therapeutics Major Product Offerings
  7.1.4 Merck Retinal Disease Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Retinal Disease Therapeutics Major Product Offerings
  7.2.4 Novartis Retinal Disease Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Allergan
  7.3.1 Allergan Corporate Summary
  7.3.2 Allergan Business Overview
  7.3.3 Allergan Retinal Disease Therapeutics Major Product Offerings
  7.3.4 Allergan Retinal Disease Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Allergan Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Retinal Disease Therapeutics Major Product Offerings
  7.4.4 Roche Retinal Disease Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Regeneron
  7.5.1 Regeneron Corporate Summary
  7.5.2 Regeneron Business Overview
  7.5.3 Regeneron Retinal Disease Therapeutics Major Product Offerings
  7.5.4 Regeneron Retinal Disease Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Regeneron Key News
7.6 Santen
  7.6.1 Santen Corporate Summary
  7.6.2 Santen Business Overview
  7.6.3 Santen Retinal Disease Therapeutics Major Product Offerings
  7.6.4 Santen Retinal Disease Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Santen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Retinal Disease Therapeutics Market Opportunities & Trends in Global Market
Table 2. Retinal Disease Therapeutics Market Drivers in Global Market
Table 3. Retinal Disease Therapeutics Market Restraints in Global Market
Table 4. Key Players of Retinal Disease Therapeutics in Global Market
Table 5. Top Retinal Disease Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Retinal Disease Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Retinal Disease Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Retinal Disease Therapeutics Product Type
Table 9. List of Global Tier 1 Retinal Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Disease Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Retinal Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Retinal Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Retinal Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Retinal Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Retinal Disease Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Retinal Disease Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Retinal Disease Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Retinal Disease Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Retinal Disease Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Retinal Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Retinal Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Retinal Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Retinal Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Retinal Disease Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Retinal Disease Therapeutics Product Offerings
Table 32. Merck Retinal Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Retinal Disease Therapeutics Product Offerings
Table 35. Novartis Retinal Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Allergan Corporate Summary
Table 37. Allergan Retinal Disease Therapeutics Product Offerings
Table 38. Allergan Retinal Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Retinal Disease Therapeutics Product Offerings
Table 41. Roche Retinal Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Regeneron Corporate Summary
Table 43. Regeneron Retinal Disease Therapeutics Product Offerings
Table 44. Regeneron Retinal Disease Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Santen Corporate Summary
Table 46. Santen Retinal Disease Therapeutics Product Offerings
Table 47. Santen Retinal Disease Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Retinal Disease Therapeutics Segment by Type in 2021
Figure 2. Retinal Disease Therapeutics Segment by Application in 2021
Figure 3. Global Retinal Disease Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Retinal Disease Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Retinal Disease Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Retinal Disease Therapeutics Revenue in 2021
Figure 8. By Type - Global Retinal Disease Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Retinal Disease Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Retinal Disease Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Retinal Disease Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Retinal Disease Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Retinal Disease Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Retinal Disease Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Retinal Disease Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Retinal Disease Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Retinal Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Retinal Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Allergan Retinal Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Retinal Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Regeneron Retinal Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Santen Retinal Disease Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)